文章摘要
晋冀两地慢病关注范围比较
Comparison of the government concern scope on chronic diseases between Shanxi and Hebei province
投稿时间:2019-03-11  修订日期:2019-03-25
DOI:
中文关键词: 慢病;关注范围;工作效果;河北;山西
英文关键词: chronic disease; Concern scope; work effect; Hebei; Shanxi
基金项目:上海市加强公共卫生体系建设三年行动计划(2015年-2017年)项目(GWIV-32),健康相关重大社会风险预警协同创新中心科研基金
作者单位邮编
刘苗苗 济宁医学院公共卫生学院
健康相关重大社会风险预警协同创新中心 
272067
郭立燕 济宁医学院公共卫生学院 
高洪彩 济宁医学院公共卫生学院 
张妍 济宁医学院公共卫生学院 
崔平 济宁医学院公共卫生学院 
李程跃 复旦大学卫生发展战略研究中心;健康相关重大社会风险预警协同创新中心 
郝模 复旦大学卫生发展战略研究中心;健康相关重大社会风险预警协同创新中心 
马安宁* 济宁医学院 272067
摘要点击次数: 652
全文下载次数: 0
中文摘要:
      目的:比较晋冀两地政府对慢性非传染性疾病关注范围的异同,分析其与当地慢病工作效果评分之间的相关性。方法:收集晋冀两地慢病领域相关的政策文件、法律规制等,根据文件中是否针对慢病设置目标,计算关注范围。运用相关、回归分析关注范围与工作效果评分之间的关系。结果:截止到2017年,山西省慢病关注范围为50.00%,河北省慢病关注范围为45.45%;晋冀两地政府慢病关注范围与当地慢病工作效果评分之间存在相关性(r山西=0.747,r河北=-0.94)。结论:适宜的公共卫生体系应广泛体现公众健康需要,适时扩大服务覆盖范围;晋冀两地关注慢病范围均明显扩大且该指标对慢病防治效果有显著影响。
英文摘要:
      Objective: To compare the similarities and differences of government concern on chronic diseases between Hebei and Shanxi province, to analyze the correlation between the concern scope and control effect score, to test the reliability and feasibility of the indicators. Methods: The research materials on the government concern of chronic diseases of Hebei and Shanxi were collected. Whether the government concern the chronic diseases depend on whether set goals in policy documents. Spearman correlation and linear regression were used to analyze the relationship between the concern scope and score. Results: By 2017, the concern scope of Shanxi is 50.00%, and the concern scope of Hebei is 45.45%; There were correlations between the concern scope and work effect score both in Shanxi and Hebei (r Shanxi=0.747, r Hebei= -0.940). Conclusion: Appropriate public health system should fully reflect public health needs and expand service coverage in due time. The concern scope for chronic disease has been significantly expanded both in Hebei and Shanxi, which had a significant impact on work effect.
View Fulltext   查看/发表评论  下载PDF阅读器

分享按钮

漂浮通知

  X

近期,网上出现以《济宁医学院学报》杂志社的名义制造的虚假网站,诱骗作者在线投稿,骗取作者版面费或收取中介费,造成恶劣影响。在此提醒广大作者,审慎辨别,谨防上当。 投稿警示:我刊对所有来稿均不收取审稿费。 投稿方式:登录济宁医学院官方网站,在左下方点击“济宁医学院学报”进入《济宁医学院学报》网页,点击作者登录,注册新用户,然后在线投稿。